MRGPRX9P

Across TCGA pan-cancer cohorts, MRGPRX9P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MRGPRX9P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MRGPRX9P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MRGPRX9P expression acts as an unfavorable survival marker, although some lineages such as HNSC and STAD show a favorable association.

BLCA, HNSC, and LUAD are the cancer types where MRGPRX9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.063	0.605	<.001	63	view →
HNSC	DFS	Tertile	All	0.943	0.591	.006	54	view →
LUAD	OS	Tertile	II,III,IV	0.203	0.711	<.001	36	view →
LUSC	DFS	Tertile	III,IV	0.218	0.662	.030	36	view →
SARC	OS	Tertile	All	0.216	0.738	<.001	30	view →
LIHC	DFS	Tertile	All	0.027	0.556	<.001	27	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	18	view →
STAD	DFS	Tertile	III,IV	0.699	0.328	.041	9	view →
COAD	DFS	Tertile	II,III,IV	0.140	0.743	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MRGPRX9P–BLCA (OS)

Open the BLCA breakdown →